potential COVID-19 treatments living meta-analysis of clinical studies

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study

	COVID-19 severe or critically

	COVID-19 (hospitalized or not)
potential COVID-19 treatments
adjuvant therapies
anticoagulant	Ayerbe HEP-COVID
anticoagulant, curative dose	Gonzalez-Porras Gonzalez-Porras
anticoagulant, pre-admission	Tremblay Rossi Russo
anticoagulant, prophylactic dose	Trinh Gonzalez-Porras Gonzalez-Porras
anti-inflammatoty and immuno-therapy
anti-inflammatory therapies	Esba
colchicine	Manenti
non-steroidal anti-inflammatory drugs	Abu Esba LC ... Park Gianfransesco Kragholm Lund
Ibuprofen	Rinott
corticosteroids	Husain Wu
Immunostimulants drugs
levamisole	Roostaei
neutralizing antibody
casirivimab/imdevimab (Ronapreve)	Wei
Immunosuppressants drugs
anti-interleukin-6
tocilizumab	Hong Zhao
statins	Zhang
antiandrogenic
5-alpha-reductase inhibitors	Lazzeri
antiviral and associated therapy
azithromycin	Hsia
chloroquine and derivatives
chloroquine	Hsia
hydroxychloroquine	Hsia
doxycycline	Husain
ivermectin	NCT04429711 ...
zinc	Abd-Elsalam
Drugs for acid related disorders
proton pump inhibitors (PPI)	Luxenburger Ullah ... Lee ...
miscellaneous
nicotin	Hopkinson
radiotherapy	Hess ...
Oral antidiabetic drugs
DPP-4 inhibitor	Rhee
Renin-angiotensin-system-acting agents	Bae Reynolds ... Anzola
angiotensin converting enzyme inhibitors (ACEIs)	Bravi Christiansen Anzola
angiotensin receptor blockers (ARBs)	Rhee Bravi Christiansen Anzola
vaccines	Bahl ...